We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical Selling Primester JV Interest to Solvay
Read MoreHide Full Article
Eastman Chemical (EMN - Free Report) has agreed to divest its interest in the Primester cellulose acetate flake joint venture in Kingsport, TN to its partner Solvay. Both companies are currently equal partners in the joint venture. The terms of the deal were not divulged.
Eastman Chemical will continue to provide some services, utilities and raw materials to Primester for Solvay’s operation of the former joint venture assets. The divestment, which is subject to satisfaction of customary closing conditions, is expected to complete in second-quarter 2016.
The sale of interest in Primester will enable Eastman Chemical to eliminate costs related to the excess cellulose acetate flake capacity of the joint venture.
The chemical maker said that it made a small capital investment last fall to beef up flake capacity at its Tennessee Eastman manufacturing facility in Kingsport. With this expansion and the shutdown of its Workington, UK acetate tow facility in 2015, it is no longer necessary for the company to support the fixed costs of Primester to have sufficient cellulose acetate flake capacity to supply all of its acetate tow capacity globally.
Eastman Chemical’s shares fell around 0.6% to close at $73.02 last Thursday.
Eastman Chemical’s profit surged in first-quarter 2016, helped by its cost-saving actions and continued momentum in its specialty businesses. Adjusted earnings topped the Zacks Consensus Estimate but sales missed expectations. Revenues fell in the quarter, hurt by lower pricing and unfavorable currency impact.
Eastman Chemical’s diversified chemical portfolio, along with its integrated and diverse downstream businesses, remain its strength. It also benefits from acquisitions, business restructuring, cost-cutting measures and increased capacity additions. However, Eastman Chemical is still faced with pricing and competitive pressures. The company is also exposed to currency headwinds.
Eastman Chemical currently sports a Zacks Rank #3 (Hold).
Better-ranked companies in the chemical space include Albemarle Corporation (ALB - Free Report) , Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) with all holding a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Eastman Chemical Selling Primester JV Interest to Solvay
Eastman Chemical (EMN - Free Report) has agreed to divest its interest in the Primester cellulose acetate flake joint venture in Kingsport, TN to its partner Solvay. Both companies are currently equal partners in the joint venture. The terms of the deal were not divulged.
Eastman Chemical will continue to provide some services, utilities and raw materials to Primester for Solvay’s operation of the former joint venture assets. The divestment, which is subject to satisfaction of customary closing conditions, is expected to complete in second-quarter 2016.
The sale of interest in Primester will enable Eastman Chemical to eliminate costs related to the excess cellulose acetate flake capacity of the joint venture.
The chemical maker said that it made a small capital investment last fall to beef up flake capacity at its Tennessee Eastman manufacturing facility in Kingsport. With this expansion and the shutdown of its Workington, UK acetate tow facility in 2015, it is no longer necessary for the company to support the fixed costs of Primester to have sufficient cellulose acetate flake capacity to supply all of its acetate tow capacity globally.
Eastman Chemical’s shares fell around 0.6% to close at $73.02 last Thursday.
Eastman Chemical’s profit surged in first-quarter 2016, helped by its cost-saving actions and continued momentum in its specialty businesses. Adjusted earnings topped the Zacks Consensus Estimate but sales missed expectations. Revenues fell in the quarter, hurt by lower pricing and unfavorable currency impact.
Eastman Chemical’s diversified chemical portfolio, along with its integrated and diverse downstream businesses, remain its strength. It also benefits from acquisitions, business restructuring, cost-cutting measures and increased capacity additions. However, Eastman Chemical is still faced with pricing and competitive pressures. The company is also exposed to currency headwinds.
Eastman Chemical currently sports a Zacks Rank #3 (Hold).
Better-ranked companies in the chemical space include Albemarle Corporation (ALB - Free Report) , Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) with all holding a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>